A 6-year-old boy is brought to the physician by his mother for a follow-up examination. He has persistent bedwetting. Over the past year, his parents have attempted various methods to prevent him from wetting his bed, including fluid restriction in the evenings, sticker rewards, and bedwetting alarms, with no improvement. The patient wets his bed 2–3 times a week. He does not have problems going to the bathroom during the day. The physician prescribes an oral medication that successfully controls his symptoms. The most likely effect of this drug on the principal cells of the kidney is increased activity of which of the following?
Q132
A 19-year-old African American male with a history of bipolar I disorder presents to the psychiatrist for a follow-up visit. During the session, the patient explains that for the past 2 months he has felt significantly fatigued and constipated. He is always complaining of feeling cold and has gained several pounds although his diet has not changed. A blood sample was sent for analysis, revealing the following: TSH - 6 mIU/L (nl = 0.4-4.0 mIU/L), free T4 - 0.4 ng/dL (nl = 0.7-1.9 ng/dL), and serum T4 - 2.1 mcg/dL (nl = 4.6-12 mcg/dL). Which of the following is responsible for these abnormalities?
Q133
A 14-year-old girl is brought by her parents to the physician because of recurrent episodes of shortness of breath and nonproductive cough over the past 3 months. She has had two episodes per week, which have resolved spontaneously with rest. Once a month, she wakes up at night with shortness of breath. Spirometry shows an FVC of 95% and an FEV1 of 85% of predicted. Treatment with inhaled budesonide-formoterol as needed is begun. Two weeks later, she is brought to the physician with acute onset of dyspnea and wheezing. Her pulse is 95/min and respirations are 32/min. Which of the following is the most appropriate initial pharmacotherapy?
Q134
An 18-year-old man is brought to the emergency department by his girlfriend because of a pruritic rash on his penis that has been present for the past hour. The rash developed shortly after the patient had protected sexual intercourse with his girlfriend for the first time. His girlfriend does not have any symptoms. Five days ago, the patient visited a friend who was complaining of intense pruritus on her elbows, wrists, groin, and axillae. The friend subsequently underwent treatment that required her to wash her bedding, clothing, and towels in hot water. Two years ago, the patient developed an itchy rash around his mouth after blowing up balloons at a birthday party. He is breathing comfortably. Vitals signs are within normal limits. Examination shows multiple well-circumscribed, raised, erythematous plaques with mild excoriations that extend from the base to the glans of the penis. The remainder of the examination shows no abnormalities. Administration of which of the following is the most appropriate next step in management?
Q135
A 6-year-old boy is brought to the physician because of a 2-week history of frequent episodes of unresponsiveness. During these episodes, he stares blankly, rhythmically nods his head, and does not respond to verbal stimulation for several seconds. Hyperventilation for 30 seconds precipitates an episode of unresponsiveness and head nodding that lasts for 7 seconds. He regains consciousness immediately afterward. An electroencephalogram shows 3-Hz spikes and waves. Which of the following best describes the mechanism of action of the most appropriate pharmacotherapy for this patient's condition?
Q136
Drug A is an experimental compound being investigated for potential use as a protectant against venous thrombosis. Binding assays reveal that the drug’s primary mechanism of action is to block carboxylation of glutamic acid residues in certain serum proteins. Drug A is most similar to which of the following:
Q137
An 11-year-old boy presents to his pediatrician for a wellness checkup. The child is an immigrant, and this is his first visit. The patient is in the 99th percentile for height and 50th percentile for weight. The child is struggling in school, and basic cognitive testing suggests he is moderately mentally disabled. His temperature is 99.5°F (37.5°C), blood pressure is 107/68 mmHg, pulse is 90/min, respirations are 17/min, and oxygen saturation is 98% on room air. Laboratory values are obtained and shown below.
Hemoglobin: 9 g/dL
Hematocrit: 30%
MCV: 110 fL
Leukocyte count: 5,500/mm^3 with normal differential
Platelet count: 192,000/mm^3
Serum:
Na+: 140 mEq/L
Cl-: 101 mEq/L
K+: 4.4 mEq/L
HCO3-: 24 mEq/L
BUN: 20 mg/dL
Glucose: 90 mg/dL
Creatinine: 1.0 mg/dL
Ca2+: 10.0 mg/dL
AST: 12 U/L
ALT: 10 U/L
The patient is started on vitamin B9 and B12. Which of the following interventions could decrease the risk for cardiac complications the most in this patient?
Q138
Seven days after undergoing bilateral total knee arthroplasty, a 65-year-old man comes to the physician with a dark discoloration and blisters on his abdomen. Current medications include simvastatin, aspirin, and low molecular weight heparin. His vital signs are within normal limits. Examination of the skin shows multiple coalescing blisters with areas of necrosis around the umbilicus. Laboratory studies show a platelet count of 32,000/mm3. Which of the following is the most likely underlying cause of this patient's symptoms?
Q139
A 62-year-old man is referred to neurology by his primary care physician. He is accompanied by his wife. The patient reports having a resting tremor in his left hand for over a year and some “stiffness” in his left arm. His wife notes that he has started to walk "funny" as well. He has a history of hypertension and hyperlipidemia. He takes aspirin, amlodipine, and rosuvastatin. On physical examination, you notice a repetitive circular movement of his left index finger and thumb that resolves with active movement of the hand. Passive motion of the left upper extremity is partially limited by rigidity. Gait is slow and shuffling. The patient is prescribed the most effective treatment for his disorder. Which of the following is the mechanism of a second drug given to prevent adverse effects of this therapy?
Q140
An 83-year-old man with advanced-stage prostate cancer comes to the physician because of a 1-week history of worsening lower back and hip pain. The patient's analgesic regimen includes oxycodone, ibuprofen, and alendronic acid. Physical examination shows localized tenderness over the lumbar spine and right hip. His current pain management requires opioid dose escalation. Which of the following opioid side effects is most likely to remain unaffected by the mechanism underlying this patient's need for a higher drug dose?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 131: A 6-year-old boy is brought to the physician by his mother for a follow-up examination. He has persistent bedwetting. Over the past year, his parents have attempted various methods to prevent him from wetting his bed, including fluid restriction in the evenings, sticker rewards, and bedwetting alarms, with no improvement. The patient wets his bed 2–3 times a week. He does not have problems going to the bathroom during the day. The physician prescribes an oral medication that successfully controls his symptoms. The most likely effect of this drug on the principal cells of the kidney is increased activity of which of the following?
A. Phospholipase C
B. Adenylate cyclase (Correct Answer)
C. Steroid hormone response element
D. Guanylate cyclase
E. Tyrosine kinase
Explanation: ***Adenylate cyclase***
- The drug prescribed is likely **desmopressin** (DDAVP), an analog of **antidiuretic hormone** (ADH), used to treat **nocturnal enuresis** by reducing urine production during the night.
- ADH binds to **V2 receptors** on the principal cells of the collecting ducts, activating **adenylate cyclase** to increase **cAMP** production, which then inserts **aquaporin-2 channels** into the apical membrane, leading to increased water reabsorption.
*Phospholipase C*
- **Phospholipase C** is typically activated by signaling pathways involving **Gq proteins**, leading to the production of **inositol triphosphate (IP3)** and **diacylglycerol (DAG)**, which then increase intracellular **calcium** and activate **protein kinase C**.
- While some ADH receptors (V1) activate phospholipase C, the **V2 receptors** in the kidney responsible for water reabsorption primarily act through **adenylate cyclase**.
*Steroid hormone response element*
- **Steroid hormones** (e.g., aldosterone, cortisol) diffuse through the cell membrane and bind to **intracellular receptors**, which then translocate to the nucleus and bind to **steroid hormone response elements** on DNA to directly alter gene transcription.
- This mechanism is associated with a slower, long-term effect on gene expression, rather than the rapid modulation of water reabsorption seen with ADH.
*Guanylate cyclase*
- **Guanylate cyclase** produces **cyclic GMP (cGMP)**, which is involved in various signaling pathways, notably those mediated by **nitric oxide (NO)** and **natriuretic peptides**.
- cGMP signaling is more commonly associated with vasodilation and regulation of blood pressure, and it is not the primary mechanism of action for ADH in water reabsorption in the kidney.
*Tyrosine kinase*
- **Tyrosine kinase receptors** are often involved in growth factor signaling, insulin action, and cytokine responses, where ligand binding leads to receptor dimerization and phosphorylation of tyrosine residues on the receptor and downstream proteins.
- This mechanism is distinct from the G protein-coupled receptor (GPCR) pathway utilized by ADH.
Question 132: A 19-year-old African American male with a history of bipolar I disorder presents to the psychiatrist for a follow-up visit. During the session, the patient explains that for the past 2 months he has felt significantly fatigued and constipated. He is always complaining of feeling cold and has gained several pounds although his diet has not changed. A blood sample was sent for analysis, revealing the following: TSH - 6 mIU/L (nl = 0.4-4.0 mIU/L), free T4 - 0.4 ng/dL (nl = 0.7-1.9 ng/dL), and serum T4 - 2.1 mcg/dL (nl = 4.6-12 mcg/dL). Which of the following is responsible for these abnormalities?
A. Valproic acid
B. Lamotrigine
C. Lithium (Correct Answer)
D. Olanzapine
E. Carbamazepine
Explanation: ***Lithium***
- The patient's symptoms (fatigue, constipation, cold intolerance, weight gain) and lab results (**elevated TSH** and **low free T4/T4**) are consistent with **hypothyroidism**.
- **Lithium** is a known mood stabilizer used in bipolar disorder that can induce hypothyroidism by interfering with thyroid hormone synthesis and release.
*Valproic acid*
- Valproic acid can cause several side effects, including **hepatotoxicity**, **pancreatitis**, and **thrombocytopenia**, but it does not typically cause hypothyroidism.
- It works by increasing GABA levels in the brain and is not known to directly affect thyroid function in a manner that would cause these symptoms and lab findings.
*Lamotrigine*
- Lamotrigine is an anticonvulsant and mood stabilizer primarily associated with dermatological side effects like **Stevens-Johnson syndrome (SJS)**.
- It is not commonly linked to thyroid dysfunction or the development of hypothyroidism.
*Olanzapine*
- Olanzapine is an atypical antipsychotic known for metabolic side effects such as **weight gain**, **hyperglycemia**, and **dyslipidemia**.
- While it can cause weight gain, it does not typically lead to the specific constellation of symptoms and thyroid hormone abnormalities seen in this patient.
*Carbamazepine*
- Carbamazepine is an anticonvulsant that can cause side effects like **hyponatremia** (due to SIADH) and **agranulocytosis**.
- Although it can rarely lead to thyroid abnormalities, it’s less commonly associated with symptomatic hypothyroidism and the specific lab profile presented compared to lithium.
Question 133: A 14-year-old girl is brought by her parents to the physician because of recurrent episodes of shortness of breath and nonproductive cough over the past 3 months. She has had two episodes per week, which have resolved spontaneously with rest. Once a month, she wakes up at night with shortness of breath. Spirometry shows an FVC of 95% and an FEV1 of 85% of predicted. Treatment with inhaled budesonide-formoterol as needed is begun. Two weeks later, she is brought to the physician with acute onset of dyspnea and wheezing. Her pulse is 95/min and respirations are 32/min. Which of the following is the most appropriate initial pharmacotherapy?
A. Salmeterol
B. Guaifenesin
C. Montelukast sodium
D. Fluticasone
E. Albuterol (Correct Answer)
Explanation: ***Albuterol***
- The girl is experiencing an acute asthma exacerbation, characterized by **dyspnea** and **wheezing** despite current therapy.
- **Albuterol** is a **short-acting beta-2 agonist (SABA)**, which provides rapid bronchodilation and is the most appropriate first-line treatment for acute asthma symptoms.
*Salmeterol*
- **Salmeterol** is a **long-acting beta-2 agonist (LABA)**, used for maintenance therapy, not for acute symptom relief.
- LABAs should always be used in combination with an inhaled corticosteroid (ICS) for long-term control.
*Guaifenesin*
- **Guaifenesin** is an **expectorant** used to thin mucus and relieve cough, but it does not address the underlying bronchospasm of asthma.
- It is not indicated for the management of acute dyspnea and wheezing in asthma.
*Montelukast sodium*
- **Montelukast** is a **leukotriene receptor antagonist** used for long-term asthma control and prevention of exercise-induced bronchoconstriction.
- It is not effective for acute asthma exacerbations requiring immediate bronchodilation.
*Fluticasone*
- **Fluticasone** is an **inhaled corticosteroid (ICS)** used for long-term asthma control to reduce airway inflammation.
- While crucial for maintenance, it does not provide rapid relief during an acute asthma attack.
Question 134: An 18-year-old man is brought to the emergency department by his girlfriend because of a pruritic rash on his penis that has been present for the past hour. The rash developed shortly after the patient had protected sexual intercourse with his girlfriend for the first time. His girlfriend does not have any symptoms. Five days ago, the patient visited a friend who was complaining of intense pruritus on her elbows, wrists, groin, and axillae. The friend subsequently underwent treatment that required her to wash her bedding, clothing, and towels in hot water. Two years ago, the patient developed an itchy rash around his mouth after blowing up balloons at a birthday party. He is breathing comfortably. Vitals signs are within normal limits. Examination shows multiple well-circumscribed, raised, erythematous plaques with mild excoriations that extend from the base to the glans of the penis. The remainder of the examination shows no abnormalities. Administration of which of the following is the most appropriate next step in management?
A. Oral cromolyn sodium
B. Intravenous acyclovir
C. Subcutaneous epinephrine
D. Oral cetirizine (Correct Answer)
E. Oral famotidine
Explanation: ***Correct Option: Oral cetirizine***
- The patient presents with **pruritic, raised, erythematous plaques** consistent with **acute urticaria (hives)**, likely triggered by an allergic reaction (probably **latex allergy** from the condom, given his history of developing a rash after blowing up latex balloons).
- **Oral antihistamines** like cetirizine (an H1 receptor blocker) are the **first-line treatment** for acute urticaria to alleviate pruritus and reduce swelling by blocking histamine effects.
- The patient is **hemodynamically stable** with a **localized reaction**, making oral antihistamines appropriate.
*Incorrect Option: Oral cromolyn sodium*
- This medication is a **mast cell stabilizer** used primarily for **asthma prophylaxis** and some allergic conditions (e.g., allergic conjunctivitis, mastocytosis).
- It is **not effective as an acute treatment** for urticaria because it prevents histamine release rather than blocking its effects once released.
- Cromolyn must be used prophylactically, not for acute symptoms.
*Incorrect Option: Intravenous acyclovir*
- Acyclovir is an **antiviral agent** used to treat **herpes simplex virus (HSV) infections**.
- The patient's rash consists of urticarial plaques, not the characteristic **grouped vesicles on an erythematous base** or **painful ulcers** seen in genital HSV.
- The acute onset immediately after exposure and the morphology are inconsistent with HSV.
*Incorrect Option: Subcutaneous epinephrine*
- **Epinephrine** is indicated for **anaphylaxis** with signs of airway compromise, bronchospasm, hypotension, or widespread systemic symptoms.
- The patient is **breathing comfortably with stable vitals**, indicating this is a **localized allergic reaction (urticaria)**, not anaphylaxis.
- There is no indication for epinephrine in isolated cutaneous reactions without systemic involvement.
*Incorrect Option: Oral famotidine*
- Famotidine is an **H2 receptor blocker** typically used to reduce gastric acid in conditions like **GERD or peptic ulcers**.
- While H2 blockers **can be used as adjunctive therapy** with H1 blockers in refractory or chronic urticaria, they are **not first-line monotherapy**.
- **H1 antihistamines are more effective** for acute urticaria and should be tried first.
Question 135: A 6-year-old boy is brought to the physician because of a 2-week history of frequent episodes of unresponsiveness. During these episodes, he stares blankly, rhythmically nods his head, and does not respond to verbal stimulation for several seconds. Hyperventilation for 30 seconds precipitates an episode of unresponsiveness and head nodding that lasts for 7 seconds. He regains consciousness immediately afterward. An electroencephalogram shows 3-Hz spikes and waves. Which of the following best describes the mechanism of action of the most appropriate pharmacotherapy for this patient's condition?
A. Inhibition of GABA reuptake into presynaptic neurons
B. Increased frequency of GABAA channel opening
C. Irreversible inhibition of GABA transaminase
D. Increased duration of GABAA channel opening
E. Blockade of thalamic T-type calcium channels (Correct Answer)
Explanation: ***Blockade of thalamic T-type calcium channels***
- The patient's presentation with **staring spells**, rhythmic head nodding, and precipitation by **hyperventilation** is classic for **absence epilepsy**. The EEG findings of **3-Hz spikes and waves** confirm this diagnosis.
- **Ethosuximide** is the first-line treatment for absence seizures. It works by selectively blocking **T-type calcium channels** in the thalamus, which are crucial for generating the 3-Hz spike-and-wave discharges.
*Inhibition of GABA reuptake into presynaptic neurons*
- This mechanism of action is characteristic of **tiagabine**, an antiepileptic drug primarily used as an add-on therapy for **focal seizures**.
- While GABAergic mechanisms are involved in epilepsy, tiagabine is not a primary treatment for absence seizures and does not target the specific thalamic pathways involved.
*Increased frequency of GABAA channel opening*
- This is the mechanism of action of **benzodiazepines**, such as **lorazepam** or **diazepam**, which enhance the inhibitory effects of GABA.
- Benzodiazepines are typically used for acute seizure management (e.g., **status epilepticus**) or as adjunct therapy, but not as first-line monotherapy for absence seizures due to sedation and tolerance issues.
*Irreversible inhibition of GABA transaminase*
- This mechanism describes **vigabatrin**, an antiepileptic drug that increases GABA levels by inhibiting its breakdown.
- Vigabatrin is primarily used for **infantile spasms** and **refractory focal seizures**, and it is associated with a risk of **visual field defects**, making it unsuitable for absence epilepsy.
*Increased duration of GABAA channel opening*
- This mechanism is characteristic of **barbiturates**, such as **phenobarbital**, which also enhance GABAergic inhibition like benzodiazepines but by increasing the duration of chloride channel opening.
- Barbiturates are older antiepileptic drugs with significant side effects (e.g., sedation) and are generally not preferred for absence seizures.
Question 136: Drug A is an experimental compound being investigated for potential use as a protectant against venous thrombosis. Binding assays reveal that the drug’s primary mechanism of action is to block carboxylation of glutamic acid residues in certain serum proteins. Drug A is most similar to which of the following:
A. Streptokinase
B. Bivalirudin
C. Warfarin (Correct Answer)
D. Heparin
E. Rivaroxaban
Explanation: ***Warfarin***
- Warfarin inhibits **vitamin K epoxide reductase**, enzyme responsible for regenerating active vitamin K.
- Active vitamin K is a cofactor for the **gamma-carboxylation of glutamic acid residues** on factors II, VII, IX, X and protein C and S. Thus, warfarin blocks their activation, inhibiting coagulation.
*Steptokinase*
- **Streptokinase** is a **thrombolytic drug** that catalyzes the conversion of **plasminogen to plasmin**, an enzyme that degrades fibrin clots.
- Its mechanism of action is focused on **breaking down existing clots**, rather than preventing their formation by affecting coagulation factor synthesis.
*Bivalirudin*
- **Bivalirudin** is a direct **thrombin inhibitor**, binding directly to the active site and exosite I of thrombin to prevent its action.
- It does not interfere with the **carboxylation of glutamic acid residues** but rather directly inhibits the final common pathway of coagulation.
*Heparin*
- **Heparin** works by potentiating the action of **antithrombin III**, which in turn inactivates thrombin and factor Xa.
- Its mechanism involves accelerating the natural anticoagulant system, rather than inhibiting the **synthesis or activation of coagulation factors** through carboxylation.
*Rivaroxaban*
- **Rivaroxaban** is a **direct factor Xa inhibitor**, which blocks the activity of free and clot-bound factor Xa.
- It directly interferes with the coagulation cascade downstream of the carboxylation step, and does not affect the **vitamin K-dependent carboxylation process**.
Question 137: An 11-year-old boy presents to his pediatrician for a wellness checkup. The child is an immigrant, and this is his first visit. The patient is in the 99th percentile for height and 50th percentile for weight. The child is struggling in school, and basic cognitive testing suggests he is moderately mentally disabled. His temperature is 99.5°F (37.5°C), blood pressure is 107/68 mmHg, pulse is 90/min, respirations are 17/min, and oxygen saturation is 98% on room air. Laboratory values are obtained and shown below.
Hemoglobin: 9 g/dL
Hematocrit: 30%
MCV: 110 fL
Leukocyte count: 5,500/mm^3 with normal differential
Platelet count: 192,000/mm^3
Serum:
Na+: 140 mEq/L
Cl-: 101 mEq/L
K+: 4.4 mEq/L
HCO3-: 24 mEq/L
BUN: 20 mg/dL
Glucose: 90 mg/dL
Creatinine: 1.0 mg/dL
Ca2+: 10.0 mg/dL
AST: 12 U/L
ALT: 10 U/L
The patient is started on vitamin B9 and B12. Which of the following interventions could decrease the risk for cardiac complications the most in this patient?
A. Folic acid supplementation
B. Homocysteine level monitoring
C. Iron supplementation
D. Pyridoxine (Vitamin B6) (Correct Answer)
E. No additional interventions needed
Explanation: ***Pyridoxine (Vitamin B6)***
- This patient has **homocystinuria** (tall stature, mental disability, macrocytic anemia) and is already on **folate (B9) and B12** supplementation
- **Pyridoxine (B6)** is the most important additional intervention because it is a cofactor for **cystathionine β-synthase**, the enzyme deficient in classical homocystinuria
- Approximately **50% of homocystinuria patients are B6-responsive**, meaning pyridoxine can dramatically reduce homocysteine levels
- The complete treatment regimen for homocystinuria includes **B6, B9 (folate), and B12** - since B9 and B12 are already started, **B6 is the critical missing intervention**
- Reducing homocysteine levels decreases risk of **thromboembolism, stroke, and cardiovascular disease**, which are the major causes of morbidity and mortality in homocystinuria
*Folic acid supplementation*
- The patient is **already receiving vitamin B9 (folic acid)** as stated in the question stem
- While folic acid is essential for lowering homocysteine through the remethylation pathway, it is already being administered
- This option would be redundant
*Homocysteine level monitoring*
- Monitoring homocysteine is important for **assessing treatment response** but is a diagnostic tool, not an intervention
- It does not directly decrease cardiac risk, though it helps guide therapy
- The question asks for an intervention that decreases risk, not a monitoring strategy
*Iron supplementation*
- The patient has **macrocytic anemia (MCV 110 fL)**, not microcytic anemia
- Macrocytic anemia suggests **folate/B12 deficiency**, not iron deficiency
- Iron supplementation would not address the underlying cause (elevated homocysteine) or reduce cardiac complications
- In fact, unnecessary iron supplementation can cause harm
*No additional interventions needed*
- This is incorrect because the standard treatment for homocystinuria requires **all three B vitamins: B6, B9, and B12**
- Since only B9 and B12 have been started, **pyridoxine (B6) is still needed** to optimally reduce homocysteine and cardiac risk
- B6 is particularly important as it addresses the underlying enzyme deficiency in many patients
Question 138: Seven days after undergoing bilateral total knee arthroplasty, a 65-year-old man comes to the physician with a dark discoloration and blisters on his abdomen. Current medications include simvastatin, aspirin, and low molecular weight heparin. His vital signs are within normal limits. Examination of the skin shows multiple coalescing blisters with areas of necrosis around the umbilicus. Laboratory studies show a platelet count of 32,000/mm3. Which of the following is the most likely underlying cause of this patient's symptoms?
A. Antibody-platelet antigen complex formation
B. Deficiency in ADAMTS13 activity
C. Anti-desmoglein antibody formation
D. Decreased production of GpIb
E. Antibody formation against heparin-PF4 complex (Correct Answer)
Explanation: ***Antibody formation against heparin-PF4 complex***
- This clinical scenario describes **Heparin-Induced Thrombocytopenia (HIT) type II**, characterized by thrombocytopenia and paradoxical thrombosis or skin necrosis, often at the injection sites.
- The **low molecular weight heparin (LMWH)** given post-surgery can induce antibodies against the heparin-platelet factor 4 (PF4) complex.
- The activation of platelets by these antibodies leads to their consumption (thrombocytopenia) and pro-thrombotic activity, resulting in skin lesions (necrosis and blisters) and potential thrombotic events.
*Antibody-platelet antigen complex formation*
- This typically refers to **Immune Thrombocytopenic Purpura (ITP)**, where antibodies are formed against platelet glycoproteins, leading to their destruction.
- ITP generally presents with mucocutaneous bleeding and does not typically cause the necrotic skin lesions seen here, nor is it directly linked to heparin administration.
*Deficiency in ADAMTS13 activity*
- This condition is characteristic of **Thrombotic Thrombocytopenic Purpura (TTP)**, presenting with microangiopathic hemolytic anemia, thrombocytopenia, renal failure, neurological symptoms, and fever (pentad).
- While TTP involves thrombocytopenia, the presentation of localized necrotic skin lesions after heparin use is not typical for TTP.
*Anti-desmoglein antibody formation*
- This is the underlying mechanism of **pemphigus vulgaris**, an autoimmune blistering skin disease.
- Pemphigus vulgaris causes widespread flaccid blisters and erosions but does not typically present with thrombocytopenia or necrosis related to heparin administration.
*Decreased production of GpIb*
- A defect in **glycoprotein Ib (GpIb)** is characteristic of **Bernard-Soulier syndrome**, a rare inherited bleeding disorder.
- This genetic disorder presents with lifelong bleeding tendencies and giant platelets, not acute thrombocytopenia and necrotic lesions triggered by medication in an older adult.
Question 139: A 62-year-old man is referred to neurology by his primary care physician. He is accompanied by his wife. The patient reports having a resting tremor in his left hand for over a year and some “stiffness” in his left arm. His wife notes that he has started to walk "funny" as well. He has a history of hypertension and hyperlipidemia. He takes aspirin, amlodipine, and rosuvastatin. On physical examination, you notice a repetitive circular movement of his left index finger and thumb that resolves with active movement of the hand. Passive motion of the left upper extremity is partially limited by rigidity. Gait is slow and shuffling. The patient is prescribed the most effective treatment for his disorder. Which of the following is the mechanism of a second drug given to prevent adverse effects of this therapy?
A. Inhibits monoamine oxidase-B
B. Activates dopamine receptors
C. Inhibits catechol-O-methyltransferase
D. Inhibits aromatic L-amino acid decarboxylase (Correct Answer)
E. Blocks muscarinic acetylcholine receptors
Explanation: ***Inhibits aromatic L-amino acid decarboxylase***
- The patient's symptoms (resting tremor, rigidity, shuffling gait, bradykinesia) are classical for **Parkinson's disease**, which is treated with **levodopa**.
- Levodopa is often co-administered with a peripheral **aromatic L-amino acid decarboxylase (AADC) inhibitor** (e.g., carbidopa) to prevent its peripheral conversion to dopamine, reducing side effects and increasing levodopa's bioavailability in the brain.
*Inhibits monoamine oxidase-B*
- **Monoamine oxidase-B (MAO-B) inhibitors** (e.g., selegiline, rasagiline) are used in Parkinson's disease to reduce dopamine breakdown, but they are not primarily given to prevent adverse effects of levodopa itself; instead, they act to prolong the effect of available dopamine.
- While they can be used adjunctively, their main role is to increase dopamine levels rather than directly mitigating levodopa's peripheral side effects.
*Activates dopamine receptors*
- **Dopamine receptor agonists** (e.g., pramipexole, ropinirole) are used in Parkinson's disease to directly stimulate dopamine receptors, either as monotherapy or adjunctively.
- They are a treatment for the disease itself, not a co-medication specifically designed to prevent adverse effects of levodopa.
*Inhibits catechol-O-methyltransferase*
- **Catechol-O-methyltransferase (COMT) inhibitors** (e.g., entacapone, tolcapone) prolong the action of levodopa by blocking its peripheral metabolism by COMT.
- While they prevent levodopa breakdown and enhance its central availability, they are typically used to extend the "on" time and manage motor fluctuations, rather than primarily preventing immediate peripheral adverse effects.
*Blocks muscarinic acetylcholine receptors*
- **Anticholinergics** (e.g., benztropine, trihexyphenidyl) block muscarinic acetylcholine receptors and are primarily used to treat the **tremor-dominant** form of Parkinson's disease.
- They do not prevent the peripheral adverse effects of levodopa; their mechanism of action is distinct and targets a different neurochemical imbalance.
Question 140: An 83-year-old man with advanced-stage prostate cancer comes to the physician because of a 1-week history of worsening lower back and hip pain. The patient's analgesic regimen includes oxycodone, ibuprofen, and alendronic acid. Physical examination shows localized tenderness over the lumbar spine and right hip. His current pain management requires opioid dose escalation. Which of the following opioid side effects is most likely to remain unaffected by the mechanism underlying this patient's need for a higher drug dose?
A. Pruritus
B. Constipation (Correct Answer)
C. Mydriasis
D. Respiratory depression
E. Nausea
Explanation: ***Constipation***
- **Opioid-induced constipation** is mediated by direct opioid receptor activation in the **enteric nervous system**, reducing gut motility.
- Unlike most other opioid side effects, the body generally does not develop **tolerance** to this effect, meaning it persists even with chronic use and dose escalation.
*Pruritus*
- **Opioid-induced pruritus** is often due to **histamine release** from mast cells, which is a common side effect of opioid administration.
- **Tolerance** can develop to pruritus over time, meaning it may lessen or resolve with chronic opioid use or dose escalation as the body adapts.
*Mydriasis*
- **Mydriasis** (pupil dilation) is not a typical opioid side effect; rather, **miosis** (pinpoint pupils) is characteristic of opioid use.
- Furthermore, **miosis** itself can exhibit some degree of **tolerance** with chronic opioid use, though it is often one of the more persistent effects.
*Respiratory depression*
- **Respiratory depression** is a serious and dose-dependent opioid side effect caused by decreased sensitivity of the respiratory center in the brainstem to CO2.
- While it is a dangerous effect, **tolerance** can develop to respiratory depression with chronic opioid use, reducing its severity over time.
*Nausea*
- **Opioid-induced nausea** is thought to be mediated by the **chemoreceptor trigger zone (CTZ)** in the brain and slowed gastric emptying.
- The body often develops **tolerance** to opioid-induced nausea within a few days to weeks of consistent opioid use.